Polunovsky (23 Ergebnisse)

Autor
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (23)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

  • Sprache: Englisch

    Verlag: Humana, 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover

    Anbieter: Brook Bookstore On Demand, Napoli, NA, ItalienBrook Bookstore On Demand

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 81,64

    EUR 6,80 Versand 
    Versand von Italien nach USA

    Anzahl: 1 verfügbar

    Zustand: new.

  • Sprache: Englisch

    Verlag: Humana, 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover

    Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 227,07

    EUR 13,17 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: New. In English.

  • Sprache: Englisch

    Verlag: Humana, 2012

    1617796948 / 9781617796944

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Softcover

    Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 227,07

    EUR 13,17 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: New. In English.

  • Weitere Bilder

    Sprache: Englisch

    Verlag: Humana, 2012

    1617796948 / 9781617796944

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Softcover

    Anbieter: preigu, Osnabrück, Deutschlandpreigu

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 184,95

    EUR 70,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 5 verfügbar

    Taschenbuch. Zustand: Neu. mTOR Pathway and mTOR Inhibitors in Cancer Therapy | Vitaly A. Polunovsky (u. a.) | Taschenbuch | Cancer Drug Discovery and Development | xii | Englisch | 2012 | Humana | EAN 9781617796944 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

  • Sprache: Englisch

    Verlag: Humana Press Inc., 2012

    1617796948 / 9781617796944

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Softcover

    Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandKennys Bookshop and Art Galleries Ltd.

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 251,96

    EUR 9,50 Versand 
    Versand von Irland nach USA

    Anzahl: 15 verfügbar

    Zustand: New. Editor(s): Polunovsky, V. A.; Houghton, Peter J. Series: Cancer Drug Discovery and Development. Num Pages: 304 pages, 3 colour tables, biography. BIC Classification: MJCL; MMG; PSF. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 17. Weight in Grams: 486. . 2012. Paperback. . . . .

  • Sprache: Englisch

    Verlag: Humana Press Inc., 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover

    Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandKennys Bookshop and Art Galleries Ltd.

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 253,22

    EUR 9,50 Versand 
    Versand von Irland nach USA

    Anzahl: 15 verfügbar

    Zustand: New. Editor(s): Polunovsky, V. A.; Houghton, Peter J. Series: Cancer Drug Discovery and Development. Num Pages: 304 pages, 3 colour tables, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 23. Weight in Grams: 695. . 2010. Hardback. . . . .

  • Sprache: Englisch

    Verlag: Humana Press, 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover

    Anbieter: Buchpark, Trebbin, DeutschlandBuchpark

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Sehr gut

    EUR 158,31

    EUR 105,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 316 | Sprache: Englisch | Produktart: Bücher | The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment ¿ targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics.

  • Sprache: Englisch

    Verlag: Humana Press, 2012

    1617796948 / 9781617796944

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Softcover

    Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 304,51

    EUR 11,66 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 2 verfügbar

    Paperback. Zustand: Brand New. 316 pages. 9.25x6.10x0.75 inches. In Stock.

  • Sprache: Englisch

    Verlag: Humana Pr Inc, 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover

    Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 305,95

    EUR 14,58 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 2 verfügbar

    Hardcover. Zustand: Brand New. 1st edition. 301 pages. 9.25x6.25x1.00 inches. In Stock.

  • Sprache: Englisch

    Verlag: Humana Press Inc., 2012

    1617796948 / 9781617796944

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Softcover

    Anbieter: Kennys Bookstore, Olney, MD, USAKennys Bookstore

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 318,29

    EUR 9,14 Versand 
    Versand innerhalb von USA

    Anzahl: 15 verfügbar

    Zustand: New. Editor(s): Polunovsky, V. A.; Houghton, Peter J. Series: Cancer Drug Discovery and Development. Num Pages: 304 pages, 3 colour tables, biography. BIC Classification: MJCL; MMG; PSF. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 17. Weight in Grams: 486. . 2012. Paperback. . . . . Books ship from the US and Ireland.

  • Sprache: Englisch

    Verlag: Humana Press Inc., 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover

    Anbieter: Kennys Bookstore, Olney, MD, USAKennys Bookstore

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 319,87

    EUR 9,14 Versand 
    Versand innerhalb von USA

    Anzahl: 15 verfügbar

    Zustand: New. Editor(s): Polunovsky, V. A.; Houghton, Peter J. Series: Cancer Drug Discovery and Development. Num Pages: 304 pages, 3 colour tables, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 23. Weight in Grams: 695. . 2010. Hardback. . . . . Books ship from the US and Ireland.

  • Sprache: Englisch

    Verlag: Humana, 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover

    Anbieter: Mispah books, Redhill, SURRE, Vereinigtes KönigreichMispah books

    Verkäufer/-in mit 4 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Wie neu

    EUR 333,92

    EUR 29,15 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 1 verfügbar

    Hardcover. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

  • Zustand: Gebraucht - Befriedigend

    EUR 178,45

    EUR 8,70 Versand 
    Versand innerhalb von USA

    Anzahl: 1 verfügbar

    In den Warenkorb

    Hardcover. Zustand: Good. In Russian. Polunovsky, Albert Grigorievich. Construction of vertical drainage piles in the construction of highways on weak ground. Moscow: 1974. All images are for identification of editions only. Several books of the same edition may be available. Please feel free to request photos of available books.SKU7329055.

  • Sprache: Englisch

    Verlag: Humana, 2012

    1617796948 / 9781617796944

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Softcover
    • Print-on-Demand

    Anbieter: Brook Bookstore On Demand, Napoli, NA, ItalienBrook Bookstore On Demand

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 166,29

    EUR 5,50 Versand 
    Versand von Italien nach USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: new. Questo è un articolo print on demand.

  • Sprache: Englisch

    Verlag: Humana, 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover
    • Print-on-Demand

    Anbieter: Brook Bookstore On Demand, Napoli, NA, ItalienBrook Bookstore On Demand

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 166,29

    EUR 6,80 Versand 
    Versand von Italien nach USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: new. Questo è un articolo print on demand.

  • Sprache: Englisch

    Verlag: Humana Press, 2012

    1617796948 / 9781617796944

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Softcover
    • Print-on-Demand

    Anbieter: moluna, Greven, Deutschlandmoluna

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 180,07

    EUR 48,99 Versand 
    Versand von Deutschland nach USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding .

  • Sprache: Englisch

    Verlag: Humana Press, 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover
    • Print-on-Demand

    Anbieter: moluna, Greven, Deutschlandmoluna

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 180,07

    EUR 48,99 Versand 
    Versand von Deutschland nach USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding .

  • Sprache: Englisch

    Verlag: Humana Press Okt 2012, 2012

    1617796948 / 9781617796944

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Softcover
    • Print-on-Demand

    Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, DeutschlandBuchWeltWeit Ludwig Meier e.K.

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 213,99

    EUR 23,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 2 verfügbar

    Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment - targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics. 316 pp. Englisch.

  • Sprache: Englisch

    Verlag: Humana Press Aug 2010, 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover
    • Print-on-Demand

    Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, DeutschlandBuchWeltWeit Ludwig Meier e.K.

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 213,99

    EUR 23,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 2 verfügbar

    Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment - targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics. 316 pp. Englisch.

  • Sprache: Englisch

    Verlag: Humana Press, Humana Aug 2010, 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover
    • Print-on-Demand

    Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschlandbuchversandmimpf2000

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 213,99

    EUR 60,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Buch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment ¿ targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 316 pp. Englisch.

  • Sprache: Englisch

    Verlag: Humana Press, Humana Press Okt 2012, 2012

    1617796948 / 9781617796944

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Softcover
    • Print-on-Demand

    Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschlandbuchversandmimpf2000

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 213,99

    EUR 60,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment ¿ targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 316 pp. Englisch.

  • Sprache: Englisch

    Verlag: Humana, 2012

    1617796948 / 9781617796944

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Softcover
    • Print-on-Demand

    Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 297,68

    EUR 30,50 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment - targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics.

  • Sprache: Englisch

    Verlag: Humana, 2010

    1603272704 / 9781603272704

    Serie: Buch 64 von 96 - Cancer Drug Discovery and Development

    • Hardcover
    • Print-on-Demand

    Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 297,68

    EUR 30,50 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment - targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics.